Sex-specific genetic determinants for arterial stiffness in Dahl salt-sensitive hypertensive rats

Julius L Decano1, Khristine A Pasion2, Nicole Black3

  • 1Department of Medicine, Whitaker Cardiovascular Institute, Boston University School of Medicine, 700 Albany Street, W-609, Boston, MA, 02118, USA. Julius113@gmail.com.

BMC Genetics
|January 13, 2016
PubMed

Insights

Genetic factors influence arterial stiffness differently in male and female rats. This study identified sex-specific quantitative trait loci (QTLs) for aortic stiffness, suggesting distinct genetic underpinnings for this cardiovascular risk factor.

Area of Science:

  • Cardiovascular Genetics
  • Physiology

Background:

  • Arterial stiffness predicts cardiovascular events in hypertension.
  • Stiffening arteries may precede high blood pressure onset.
  • Genetic factors and sex differences in arterial stiffening are unclear.

Purpose of the Study:

  • Investigate shared or distinct genetic determinants of arterial stiffening in male and female Dahl rats.
  • Identify quantitative trait loci (QTLs) for arterial stiffness traits.

Main Methods:

  • Genome-wide scan for QTLs in male and female F2 (Dahl S x R)-intercross rats.
  • High-resolution ultrasonography to measure abdominal aortic pulse wave velocity and aortic strain.
  • Analysis of sex-specific and sex-independent QTLs.

Main Results:

  • Five significant QTLs for aortic stiffness were detected: two interacting QTLs in males (chromosomes 4, 16) and two in females (chromosomes 9, 11).
  • One QTL on chromosome 3 influenced aortic strain independently of sex.
  • No arterial stiffness QTLs overlapped with previously identified blood pressure QTLs.

Conclusions:

  • Sex-specific genetic factors determine aortic pulse wave velocity.
  • Distinct polygenic susceptibility exists for arterial stiffness and salt-sensitive hypertension in Dahl rats.
Abstract

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.4K
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
3.0K
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
4.8K